Biotech CEO Paul Perreault On Treating Rare Diseases & Developing New Drugs

Paul Perreault, the CEO of one of the world’s largest biotechnology companies visited Penn State University Park recently. He talked with WPSU’s Carolyn Donaldson about the work of his company, CSL Behring. The company focuses on developing drugs to treat rare diseases, improving existing drugs and advancing the field of gene therapy.